Skip to main content
Neuland Laboratories Limited (NSE:NEULANDLAB)
India flag India · Delayed Price · Currency is INR
13,278
+260 (2.00%)
Aug 14, 2025, 3:29 PM IST

Neuland Laboratories Revenue

Neuland Laboratories had revenue of 2.93B INR in the quarter ending June 30, 2025, a decrease of -33.41%. This brings the company's revenue in the last twelve months to 13.30B, down -18.66% year-over-year. In the fiscal year ending March 31, 2025, Neuland Laboratories had annual revenue of 14.77B, down -5.24%.

Revenue (ttm)
13.30B
Revenue Growth
-18.66%
P/S Ratio
12.80
Revenue / Employee
7.41M
Employees
1,794
Market Cap
170.18B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202514.77B-817.43M-5.24%
Mar 31, 202415.59B3.67B30.81%
Mar 31, 202311.91B2.40B25.20%
Mar 31, 20229.52B147.07M1.57%
Mar 31, 20219.37B1.73B22.64%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sun Pharmaceutical Industries 537.77B
Divi's Laboratories 96.52B
Cipla 274.80B
Apollo Hospitals Enterprise 225.51B
Mankind Pharma 129.10B
Zydus Lifesciences 236.08B
Fortis Healthcare 80.94B
Aurobindo Pharma 320.25B
Revenue Rankings

Neuland Laboratories News

More News